Feds lower expectations for open enrollment period

 

The Department of Health & Human Services has lowered its prediction for the number of enrollees from 13 million to 9-9.9 million for coverage through state and federal exchanges for 2015, reports Modern Healthcare

The agency anticipates that 75-80 percent will be individuals who are currently uninsured.

Read more below:

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.